- Home
- MRCC vs MYO Comparison
MRCC vs MYO Comparison
Compare MRCC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRCC
- MYO
- Stock Information
- Founded
- MRCC 2011
- MYO 2004
- Country
- MRCC United States
- MYO United States
- Employees
- MRCC N/A
- MYO N/A
- Industry
- MRCC Investment Managers
- MYO Industrial Specialties
- Sector
- MRCC Finance
- MYO Health Care
- Exchange
- MRCC Nasdaq
- MYO Nasdaq
- Market Cap
- MRCC 176.4M
- MYO 153.0M
- IPO Year
- MRCC 2012
- MYO 2017
- Fundamental
- Price
- MRCC $6.47
- MYO $3.56
- Analyst Decision
- MRCC Hold
- MYO Strong Buy
- Analyst Count
- MRCC 1
- MYO 4
- Target Price
- MRCC $8.00
- MYO $9.50
- AVG Volume (30 Days)
- MRCC 109.5K
- MYO 607.2K
- Earning Date
- MRCC 05-07-2025
- MYO 05-07-2025
- Dividend Yield
- MRCC 15.36%
- MYO N/A
- EPS Growth
- MRCC 3301.50
- MYO N/A
- EPS
- MRCC 0.32
- MYO N/A
- Revenue
- MRCC $56,983,000.00
- MYO $38,628,624.00
- Revenue This Year
- MRCC N/A
- MYO $55.29
- Revenue Next Year
- MRCC N/A
- MYO $27.18
- P/E Ratio
- MRCC $20.03
- MYO N/A
- Revenue Growth
- MRCC N/A
- MYO 97.60
- 52 Week Low
- MRCC $6.44
- MYO $2.76
- 52 Week High
- MRCC $8.85
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- MRCC 38.32
- MYO 38.02
- Support Level
- MRCC $6.80
- MYO $3.08
- Resistance Level
- MRCC $7.14
- MYO $3.44
- Average True Range (ATR)
- MRCC 0.28
- MYO 0.28
- MACD
- MRCC -0.03
- MYO -0.11
- Stochastic Oscillator
- MRCC 33.03
- MYO 25.16
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).